All of the numbers and assumptions that make sense indicate that 2% is about right. But we are still in the early stages, and once health care systems get overwhelmed then the fatality rate should increase.
I expect that this year's death rate from the flu will be much lower than typical because COVID-19 is going to cull the people most at risk from the flu first.
Has anyone heard any results from the trials of remdesivir? (The Gilead anti-viral fast tracked into clinical trials on coronavirus patients)